RAN and neoplasm: Importantly, RNAi-mediated knockdown of Ran in various tumour cell types cause aberrant mitotic spindle formation, mitochondrial dysfunction and apoptosis, while knockdown in non-tumour cells is well tolerated and does not lead to mitotic defects or loss of cell viability [9].